Abstract
Patients with Alpha-1 Antitrypsin Deficiency (A1AD) have abnormally low levels of the protein Alpha-1 Antitrypsin (AAT) in their blood, because of a double mutation that makes the protein misfold and instead collect in the liver (sometimes even causing cirrhosis). The currently accepted single dosage (SD) of AAT supplements does not produce AAT blood concentrations anywhere near normal levels; they typically only reach the effect of having a single mutation. Some have therefore advocated for a double dosage (DD) of these treatments, which generally would be enough to approach these normal concentrations. Levels of cytokines, produced by the immune system in response to an attack, have already been observed to drop dramatically when A1AD patients consuming single dosage started taking double dosage, and then either remain the same or increase again upon return to a single dosage regimen. In this study we administer the same dosage sequence to A1AD patients (SD, DD, SD) for one month each and view the effects on their lung microbiome and metabolome. We analyze both at the end of each stage, comparing and contrasting and discovering potential biomarkers for each stage, and concluding with a discussion of potential implications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Barker, M., Rayens, W.: Partial least squares for discrimination. J. Chemometr. 17(3), 166–173 (2003)
Bolger, A.M., Lohse, M., Usadel, B.: Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30(15), 2114–2120 (2014)
Brebner, J.A., Stockley, R.A.: Recent advances in -1-antitrypsin deficiency-related lung disease. Expert Rev. Respir. Med. 7(3), 213–230 (2013)
Breiman, L.: Random forests. Mach. Learn. 45(1), 5–32 (2001). https://doi.org/10.1023/A:1010933404324
Campos, M.A., et al.: The biological effects of double-dose AAT augmentation therapy. Am. J. Respir. Crit. Care Med. 200(3), 318–326 (2019)
Campos, M.A., et al.: Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in A1AD: a multicenter, randomized, double-blind, crossover study (SPARK). COPD: J. Chronic Obstr. Pulm. Dis. 10(6), 687–695 (2013)
Caporaso, J.G., et al.: QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7(5), 335–336 (2010)
Chao, A., Chazon, R.L., Colwell, R.K., Shen, T.: A new statistical approach for assessing similarity of species composition with incidence and abundance data. Ecol. Lett. 8, 148–159 (2005)
Chmiel, J.F., et al.: Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann. Am. Thorac. Soc. 11(7), 1120–1129 (2014)
Chung, K.F.: Potential role of the lung microbiome in shaping asthma phenotypes. Ann. Am. Thorac. Soc. 14(S5), S326–S331 (2017)
Cickovski, T., Peake, E., Aguiar-Pulido, V., Narasimhan, G.: ATria: a novel centrality algorithm applied to biological networks. BMC Bioinformatics 18, 239–248 (2017). https://doi.org/10.1186/s12859-017-1659-z
Derr, T., Wang, S., Wang, C., Tang, J.: Relevance measurements in online signed social networks. In: The 14th International Workshop on Mining and Learning with Graphs, London, UK, August 2018
Edgar, R.C.: USEARCH and UCLUST algorithms. Bioinformatics 26(19), 2460–2461 (2010)
Fernandez, M., Riveros, J.D., Campos, M., Mathee, K., Narasimhan, G.: Microbial “social networks”. BMC Genomics 16(11), 1 (2015)
Frey, B.J., Dueck, D.: Clustering by passing messages between data points. Science 315(5814), 972–976 (2007)
Fruchterman, T.M.J., Reingold, E.M.: Graph drawing by force-directed placement. Softw. Pract. Exper. 21(11), 1129–1164 (1991)
Heid, C.A., Stevens, J., Livak, K.J., Williams, P.M.: Real-time quantitative PCR. Genome Res. 6, 986–994 (1996)
Hubbard, R.C., Sellers, S., Czerski, D., Stephens, L., Crystal, R.G.: Biochemical efficacy and safety of monthly augmentation therapy for A1AD. JAMA 260(9), 1259–1264 (1988)
Hunt, J.M., Tuder, R.: Alpha-1 anti-trypsin: one protein, many functions. Curr. Mol. Med. 12(7), 827–835 (2012)
John, J.S.: SeqPrep (2019). https://github.com/jstjohn/SeqPrep
Kanehisa, M., Goto, S.: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27–30 (2000)
Kanmani, P., et al.: Respiratory commensal bacteria Corynebacterium pseudodiptheriticum improves resistance of infant mice to respiratory syncytial virus and Streptococcus pneumonias superinfection. Front. Microbiol. 8, 1613 (2017)
Karp, P., Paley, S., Romero, P.: The pathway tools software. Bioinformatics 18(suppl 1), S225–S232 (2002)
Kozich, J.J., Westcott, S.L., Baxter, N.T., Highlander, S.K., Schloss, P.D.: Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq illumina sequencing platform. Appl. Environ. Microbiol. 79(17), 5112–5120 (2013)
Krebs, H.A.: The citric acid cycle. Biochem. J. 34(3), 460–463 (1940)
Laurell, C.B., Eriksson, S.: The electrophoretic Alpha1-Globulin pattern of serum in Alpha1 antitrypsin-deficiency. Scand. J. Clin. Lab. Invest. 15(12), 132–140 (1963)
O’Dwyer, D.N., Dickson, R.P., Moore, B.B.: The lung microbiome, immunity and the pathogenesis of chronic lung disease. J. Immunol. 196(12), 4839–4847 (2017)
Oliveira, G.P., de Abreu, M.G., Pelosi, P., Rocco, P.R.M.: Exogeneous glutamine in respiratory diseases: myth or reality? Nutrients 8(2), 76 (2016)
Padmanaban, A., Inche, A., Gassman, M.: High-throughput DNA sample QC using the agilent 2200 tapestation system. J. Biomol. Tech. 24(Suppl), S41 (2013)
Purves, D., et al.: Neuroscience, 4th edn. Sinauer Associates, Sunderland (2008)
Quast, C., et al.: The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2013)
Ruiz-Perez, D., Guan, H., Madhivanan, P., Mathee, K., Narasimhan, G.: So you think you can PLS-DA? In: International Conference on Computational Advances in Bio and Medical Sciences, ICCABS 2018. IEEE (2018)
Sazal, M., Ruiz-Perez, D., Cickovski, T., Narasimhan, G.: Inferring relationships in microbiomes from signed bayesian networks. In: International Conference on Computational Advances in Bio and Medical Sciences, ICCABS 2018. IEEE (2018)
Schafer, J., Griese, M., Chandrasekaran, R., Chotirmall, S.H., Hartl, D.: Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis. BMC Pulm. Med. 18, 79 (2018). https://doi.org/10.1186/s12890-018-0630-8
Segata, N., et al.: Metagenomic biomarker discovery and explanation. Genome Biol. 12(6), R60 (2011)
Sender, R., Fuchs, S., Milo, R.: Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14(8), e1002533 (2016)
Shannon, C.E.: A mathematical theory of communication (1963). Bell Syst. Tech. J. 27, 379–423 (1948)
Sharp, H.L., Bridges, R.A., Krivit, W., Freier, E.F.: Cirrhosis associated with A1AD: a previously unrecognized inherited disorder. Trans. Res. 73(6), 934–969 (1969)
Spearman, C.: The proof and measurement of association between two things. Am. J. Psychol. 15(1), 72–101 (1904)
Steemers, F.J., Gunderson, K.L.: Illumina, Inc. Pharmacogen 6(7), 777–782 (2005)
Stoller, J.K., Aboussouan, L.S.: 1-antitrypsin deficiency \(\cdot \) 5: intravenous augmentation therapy: current understanding. Thorax 59(8), 708–712 (2004)
Surette, M.G.: The cystic fibrosis lung microbiome. Ann. Am. Thorac. Soc. 11(S1), S61–S65 (2014)
Tyson, G.W., et al.: Community structure and metabolism through reconstruction of microbial genomes from the environment. Nature 428, 37–43 (2004)
Xia, J., Sinelnikov, I.V., Han, B., Wishart, D.S.: MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic Acids Res. 43(W1), W251–W257 (2015)
Acknowledgment
GN and KM were supported by National Institute of Health (580 #1R15AI128714-01). GN was also supported by Department of Defense (581 #W911NF-16-1-0494) and the National Institute of Justice (582 #2017-NE-BX-0001). GN, KM and MC were supported by the Florida Department of Health (FDOH 09KW-10) and the Alpha-One Foundation. TC received support from NVIDIA and Florida International University. The authors also thank colleagues from the BioRG for many useful discussions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Cickovski, T., Manuel, A., Mathee, K., Campos, M., Narasimhan, G. (2020). Effects of Various Alpha-1 Antitrypsin Supplement Dosages on the Lung Microbiome and Metabolome. In: Măndoiu, I., Murali, T., Narasimhan, G., Rajasekaran, S., Skums, P., Zelikovsky, A. (eds) Computational Advances in Bio and Medical Sciences. ICCABS 2019. Lecture Notes in Computer Science(), vol 12029. Springer, Cham. https://doi.org/10.1007/978-3-030-46165-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-46165-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46164-5
Online ISBN: 978-3-030-46165-2
eBook Packages: Computer ScienceComputer Science (R0)